https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
- Forums
- ASX - By Stock
- SPL
- If Viraleze 7 day treatment is competing with Paxlovid - who wins
SPL
starpharma holdings limited
Add to My Watchlist
4.00%
!
12.0¢

If Viraleze 7 day treatment is competing with Paxlovid - who wins
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $50.18M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 11.5¢ | $3.755K | 31.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 63402 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 106947 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33402 | 0.115 |
2 | 9099 | 0.110 |
2 | 126900 | 0.105 |
5 | 543009 | 0.100 |
1 | 30303 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 106947 | 2 |
0.130 | 323620 | 3 |
0.135 | 230549 | 8 |
0.140 | 155336 | 3 |
0.145 | 13227 | 4 |
Last trade - 15.41pm 12/09/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |